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AUTHORS 
Fabian M. Teichmann is an attorney-at-law and public notary in Switzerland. After earn-
ing an undergraduate degree in Economics and Finance (Bocconi University, Italy), he 
then earned graduate degrees in Management (Harvard University, USA), Accounting 
and Finance, and Law (University of St. Gallen, Switzerland). He also holds a PhD in 
Law (University of Zurich, Switzerland), a Doctorate in Economics and Social Sciences 
(Kassel University, Germany), and an LL.M. (King’s College, England). Teichmann 
teaches courses on compliance, corruption, money laundering, and terrorism financing at 
various universities. He is the author of several books and over 100 scholarly articles. 
 
Marie-Christin Falker is a research associate at Teichmann International (Schweiz) AG. 
She obtained an undergraduate degree in English and American Culture and Business 
Studies, focusing particularly on international management and marketing (Kassel Uni-
versity, Germany). She also studied at University of Maryland at College Park (USA) 
during her undergraduate studies. 
REVIEWED BOOK 
The book critically assesses cooperation in the German healthcare sector. In particular, it 
analyzes the role of bribery and discusses various forms of legal and illegal cooperation with 
and between healthcare institutions. In this context, it also provides a detailed overview of 
competition law implications. The book concludes by illustrating the practical role of bribery 
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Medical compliance is becoming increasingly important throughout the world. In partic-
ular, corruption appears to influence the procurement of pharmaceuticals and medical 
equipment in developing economies, such as China1 and Bulgaria.2 This is easily explained 
by high levels of corruption in these countries.3 In addition, the medical procurement 
sphere is traditionally characterized by very high levels of bribery.4 However, corruption 
in medical procurement is also an issue in the most developed countries such as Germany. 
Hence, this book is of enormous practical importance and relevance. The authors success-
fully combine expert scientific insight with discussion of practical implications. It was a 
pleasure to read their analyses, as the findings are presented in an interesting narrative 
style, which induces curiosity in the reader. The authors also explore groundbreaking 
themes. 
 
The work pursues an interdisciplinary approach to assessing cooperation in healthcare, 
especially involving the medication and pharmaceutical industry. The current challenge 
in this domain is to meet patients’ expectations while also justifying the legality of coop-
eration. As the authors expressly state, their book contributes to understanding this justi-
fication with reference to criminal law and “the legal perspectives of social, professional, 
fair competition, and antitrust laws.”5 Further, it aims to “give a comprehensive view of 
the enforcement practices in fighting corruption in healthcare, from the perspectives of 
both the public prosecutor and the defense.”6 
 
In his chapter on bribery and bribability, Prof. Dr. Schneider thoroughly delineates the 
elements of an offense under sections 299a and 299b of the German Criminal Code 
(StGB) and how these are construed. He elaborately defines the characteristics of these 
sections by discussing their structures, identifying disparities, and explaining implica-
tions. Further, the paradigm shift on April 13, 2016 is examined brilliantly through an as-
tute assessment from a criminal policy perspective of sections 299a and 299b StGB, which 
became effective on June 4, 2016. Moreover, the chapter profiles potential offenders, 
namely healthcare professionals, who must complete a government-regulated education 
before being authorized to enter the profession. Schneider provides an elaborate overview 
of medical professions and distinguishes them from health trade professions. He also il-
lustrates the German legal situation and discusses foreign healthcare providers. Other 
content includes examples of bribery from the perspectives of both payers of bribes, as 
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well as receivers of bribes, the exploration of competitive and market behavior, and addi-
tional legal definitions. 
 
Prof. Dr. Schneider’s detailed and thorough exploration of the issue is not only highly 
informative but also inspires a desire to learn more. He successfully illuminates bribery in 
healthcare from multiple perspectives while also basing his reflections on legal expertise. 
His excellent points are written in an absorbing manner. In his superb overview of both 
active and passive bribery in the healthcare sector, Schneider succeeds in concisely sum-
marizing all relevant aspects for the reader. He profoundly analyzes the various elements 
of the relevant crimes, focusing especially on sections 299a and 299b StGB. 
 
Chapter 4 was written by attorney-at-law Claus Burghardt and dissects cooperation in 
healthcare. After competently illustrating cooperation in healthcare and its manifesta-
tions, he discusses insurance contracts and patient compliance initiatives. He also thor-
oughly investigates consultant contracts and other service contracts. Finally, Burghardt 
provides an interesting and informative examination of financial support for continuing 
medical education. Like Schneider, he excels in his analysis, which is both comprehensive 
and engaging. 
 
In Chapter 5 attorney-at-law Dr. Daniel Geiger analyzes cooperation with institutions, 
which entails sponsoring, donations, and third-party funding. We were particularly in-
trigued by his analysis of external funding acquisition through institutions and universi-
ties. Geiger argues that university law and criminal law must be brought in line on what 
constitutes an “advantage” according to corruption delicts (§§ 331 ff. StGB). His illustra-
tions are extensive, and his discussion of the issue combines a scientific viewpoint with 
practical implications. Moreover, the theme builds on previous chapters, and so is well 
integrated into the book’s overall narrative. 
 
Unfair competition concerns are highlighted in Chapter 6, which is authored by attorney-
at-law Michael Weidner. He examines the legal implications of cooperation with pharma-
cies, including discounts on both prescription and over-the-counter medications. 
Weidner then compellingly debates advanced education measures for pharmacists con-
cerning products, sales, and scientific content. He also discusses marketing formats, such 
as promotional gifts, shop window renting and placement, print advertisements, and 
more. Weidner’s contribution offers fascinating insights and fits seamlessly with the con-
tent of the preceding chapters. 
 
Chapter 7 addresses the antitrust implications of sections 299a and 299b StGB. Attorney-
at-law Dr. Christian Burholt impressively discusses issues, such as discounts for pharma-
cists, medical deliveries, and the German and EU antitrust legislation governing the grant-
ing of discounts. After delineating the history of sections 299a and 299b, he details viola-
tions of antitrust laws and market abuse restraints. Burholt succeeds in conveying the key 
points in an intriguing manner. His analysis of different types of discounts is comprehen-
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The practical implications of corruption in healthcare are documented in Chapter 8, 
which gives insights into penal praxis. Its co-authors – Alexander Badle, Christian Konrad 
Hartwig, and Dr. Andreas Raschke – provide an extremely elaborate and detailed analysis 
of a multitude of associated aspects. The chapter begins by explaining the principle of 
legality. It then considers how anonymous complaints are investigated, covering the in-
vestigation procedure in detail. The presentation of their findings is both informative and 
compelling, with particularized descriptions that are in no way prosaic or irrelevant. Es-
pecially interesting is the analysis of the potential for conflict between the corporation 
and their employees induced by internal investigations, as well as limitations due to med-
ical secrecy, and two-stage examinations based on consent or anonymization. In addition, 
the authors discuss authorities’ utilization of the media, which is a highly relevant and 
entertaining topic. Finally, their conclusion summarizes the discussed points and forecasts 
how the work of authorities will develop in the future with regards to medical science 
laws. 
 
The final chapter considers the criminal defense of individuals and companies charged 
with corruption under sections 299a and 299b StGB. Attorney-at-law Felix Rettenmaier 
gives a knowledgeable description of how an investigation develops and isolates criminal 
offenses that could lead to a criminal charge. He then describes the ensuing investigative 
procedure and analyzes potential defense strategies. Rettenmaier details possible 
measures, such as temporary employment bans and searches. He also compellingly ex-
plains who is affected when an investigation ensues, and how those individuals or groups 
could be defended. In particular, he skillfully depicts how to execute a defense in a cor-
ruption investigation, illuminating every single step of the procedure: counseling clients 
determining the state of affairs, evaluating circumstances, and formulating the defense 
strategy. Rettenmaier is immensely thorough in detailing the process, which facilitates 
deep understanding of the attorney’s activities in such cases. Finally, he stipulates the con-
sequences for companies, thus reinforcing the book’s practical relevance. 
 
Overall, the entire book combines highly informative content with suspenseful and ab-
sorbing writing. The authors succeed in presenting legal issues that some might consider 
prosaic in a manner that maintains readers’ interest throughout. Indeed, the authors give 
a “comprehensive overview of nearly all practically relevant case constellations and their 
legal appraisal.”7 The book is of utmost importance for both academics and practitioners 
in the field of medical compliance. 
	
		
7  Id. at 35. 
